Optimizing the Management of Patients with Advanced Non-Melanoma Skin Cancers in Community-based Dermatology, Oncology, and Dermato-oncology Practices
Case Presentations: Treatment, Management Strategies, and Clinical Trial Data
Post-Test/Evaluation
Questions marked with a
*
are required
37%
Contact Information
First Name
Last Name
Email Address
Credentials/Degree (MD, DO, RN, etc.)
Date of Participation
Month
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Day
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Year
2018
2019
2020
2021
2022
2023
2024
2025
An 82-year-old male with a 10 year history of BCC presents with a new lesion on the left upper eyelid. He had a history of relapses treated with surgery and reconstruction procedures. When surgery was no longer a treatment option, he was treated with sonidegib. What is the best treatment option to offer this patient?
A. Surgical excision
B. Sonidegib
C. Cemiplimab-rwlc
D. Pembrolizumab
In EMPOWER-CSCC-1, what percentage of patients with locally advanced cSCC had disease control?
A. 20% to 30%
B. 35% to 46%
C. 54% to 67%
D. 63% to 76%
What is your job role?
Dermatologic Oncologist
Head and Neck Surgeon
Radiation Oncologist
Medical Oncologist
Pharmacist
Dermatologist
Hematologist
Nurse Practitioner
Physician Assistant
Internist
Other
What is your type of practice?
Community/Private
Clinic
Academic
Hospital
HMO/MCO
Other
How many years have you been in practice?
Fewer than 5
5 to 9
10 to 15
More than 15
N/A
Please estimate the number of patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas that you treat each month:
1-10
11-25
26-50
51-75
> 75
N/A
Start
Powered by
QuestionPro
Loading...
close
drag_indicator
close
Yes
Cancel
Continue
Answer Question
Continue Without Answering
Keep Data
Discard
close